National Cancer Institute - Dictionary of Cancer Terms

	Quick Links


	Dictionary Funding Opportunities NCI Publications NCI Calendar Español

	NCI Highlights


	Chemo Extends Life in Advanced Prostate Cancer Temozolomide Plus Radiation Helps Brain Cancer Confirmed: Raloxifene Drops Risk of Breast Cancer Bortezomib Delays Progression of Multiple Myeloma Annual Report to the Nation Past Highlights

YM598

A substance that is being studied as a treatment for advanced prostate cancer and for pain caused by prostate cancer that has spread to the bone. It belongs to the family of drugs called endothelin ETA receptor antagonists.

yttrium (IH-tree-um)

A rare elemental metal. A radioactive form of yttrium is used in radiation therapy and some types of immunotherapy.

yttrium Y 90 ibritumomab tiuxetan

An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.

yttrium Y 90 SMT 487

A substance that is being studied as a treatment for cancer. Also called yttrium Y 90-DOTA-tyr3-octreotide.

yttrium Y 90-DOTA-tyr3-octreotide

A substance that is being studied in the treatment of cancer. Also called yttrium Y 90 SMT 487.